Company Filing History:
Years Active: 2022
Title: Innovations in Endovascular Ablation: The Contributions of Anne Marie Ahonen
Introduction
Anne Marie Ahonen, an esteemed inventor based in Lenexa, Kansas, has made significant strides in the field of medical technology. With two patents to her name, she has been instrumental in developing novel methods for endovascular ablation, specifically targeting the splanchnic nerve to combat heart failure and hypertension.
Latest Patents
Ahonen's latest patents focus on "Methods and devices for endovascular ablation of a splanchnic nerve" and "Systems, devices, and methods for transvascular ablation of target tissue." These innovative devices and methodologies aim to enhance splanchnic venous blood capacitance. By doing so, they provide a promising treatment option for conditions such as heart failure and hypertension. The disclosed devices can be advanced endovascularly towards a target vessel in the region of the thoracic splanchnic nerve, including the greater splanchnic nerve or the TSN nerve root. This groundbreaking approach also includes methods for treating heart failure, such as HFpEF, by endovascularly ablating the thoracic splanchnic nerve, thereby increasing venous capacitance and reducing pulmonary blood pressure.
Career Highlights
Currently affiliated with Axon Therapies, Inc., Anne Marie Ahonen leverages her expertise to further innovations in medical treatments. Her commitment to advancing healthcare technology has positioned her as a key figure in her field. Ahonen's career is marked by her ability to translate complex medical challenges into practical, innovative solutions that promise to enhance patient outcomes.
Collaborations
Throughout her career, Ahonen has collaborated with notable professionals in the industry, including Pajhand Iranitalab and Casey Andrew Miller. These partnerships underscore the collaborative effort necessary to drive innovation in healthcare, combining diverse expertise and perspectives to achieve groundbreaking results.
Conclusion
Anne Marie Ahonen stands out as a pioneering inventor whose contributions to endovascular ablation techniques play a crucial role in the treatment of heart failure and hypertension. Her patents not only represent individual achievements but also reflect the potential for innovation in medical technology to enhance patient care. With her continued dedication and collaboration within the field, she is likely to foster further advancements that could transform clinical practice.